BIOMARKERS US 2024

Ensuring robust biomarker validation & identification to improve clinical outcomes, enable better diagnosis & facilitate precision medicine

Explore the latest developments in the biomarker field through the 8th Annual Biomarker & Precision Medicine US Congress, which brings together experts from global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions all focussed on emerging tools and strategies within translational science, diagnostics and biomarker development.

Enable effective biomarker identification and characterization across multiple disease areas, including neuroscience, oncology & rare disease, to accelerate novel drug candidates to commercially successful products

Integrate multi-omic technologies into your workflows to drive the development of precision medicines, with discussion of spatial technologies, single cell analysis and AI-driven imaging

Gain novel insights into next-generation diagnostic tools in order to improve clinical outcomes. Further talks look at the implementation of companion diagnostics in drug development to enable therapeutic success

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences.

The 2024 programme will delve into the intricacies of navigating regulatory barriers in clinical trials, with a specific focus on companion diagnostics (CdX) and the complexities of biomarkers. Discussions will also revolve around the pivotal role of biomarkers in clinical development, exploring advancements in spatial tissue imaging and the integration of AI technologies in biomarker research. With precision medicine also at the forefront, key opinion leaders will examine how these innovations are shaping the landscape of healthcare and the future of personalized treatment approaches within clinical trials.

• Are image analysis algorithms for digital pathology compliant with regulatory requirements?
• Next – Gen Digital Pathology Conference
• DIGITAL PATHOLOGY APPLICATIONS: From Clinical Practice to Drug Development
• HALO® 4.0 Sneak Peek
• HALO AI 4.0 Sneak Peek